Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks ...

Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...

Delays in providing first medical contact to device time for STEMI can result in worse patient outcomes, highlighting the ...

A study has shown that patients who have experienced acute myocardial infarction have a higher risk of developing blood ...

Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

CARDIOVASCULAR diseases (CVDs) continue to be the leading cause of death in the Philippines, with access to timely and ...

The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...

Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...

Background: Major noncardiac surgery carries high rates of postoperative myocardial injury and other complications. Remote ischemic preconditioning (RIPC) was reported to decrease these complications.